1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Boston Scientific Unveils European Market Launch Of PROMUS Element Plus – NASDAQ

February 1, 2012Immunosuppressive Drugsadmin

Boston Scientific Unveils European Market Launch Of PROMUS Element Plus
NASDAQ
(BSX) announced first patient use and European market launch of the PROMUS Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System. The company said the new stent system incorporates the platinum chromium or PtCr alloy and innovative ...
Boston Scientific Announces First Implant and Market Launch of PROMUS Element ...PR Newswire (press release)
Drug-eluting stent: Boston Scientific launches new Promus Element Plus in EUMass Device

all 17 news articles »

Post navigation

← MSPs backing organ donor law change now total 64 HALF OF HOLYROOD GET BEHIND … – Glasgow Evening Times Medtronic Announces First Patient Enrollment In IMPROVE HF Bridge Study – NASDAQ →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos